Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP-UK, MACP (USA), Dip in Endocrinology UKAP (UK)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP-UK, MACP (USA), Dip in Endocrinology UKAP (UK)
Nephrologist
MBBS, FCPS (Nephrology)
Gastroenterologist
M.B.B.S, M.C.P.S (Medicine), F.C.P.S (Gastroenterology)
Gastroenterologist
M.B.B.S, M.C.P.S (Medicine), F.C.P.S (Gastroenterology)
Gastroenterologist
MBBS, FCPS (Gastroenterologist)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Internal Medicine Specialist
MBBS, Diploma in Internal Medicine, Certified in Diabetes, Certified in Endocrinology
Internal Medicine Specialist
MBBS, Diploma in Internal Medicine, Certified in Diabetes, Certified in Endocrinology
Internal Medicine Specialist
MBBS, MD (Internal Medicine)
Gastroenterologist
MBBS, FCPS Gastroenterology
Gastroenterologist
MBBS, MACG (USA), MD (Gastroenterology)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures